Search the Newsreel

Affiliated Managers Group (NYSE:AMG) Announces Earnings Results

Iamgold (IAG) Projected to Release Earnings on Thursday

Amgen (AMGN) Wins Backing In Europe For Broader Repatha Use

Amgen's Repatha has received positive backing from the European Medicines Agency's CHMP for an expanded indication to reduce cardiovascular risk in high-risk adult patients without a prior heart attack or stroke. This recommendation is based on strong Phase 3 clinical data. The decision could …

IAMGOLD Corp (IAG) Institutional Confidence

This article from TradingKey provides an overview of IAMGOLD Corp's (IAG) institutional confidence. It details the current stock price, market capitalization, P/E ratio, and highlights institutional shareholding data. The data includes the number of shares held and the percentage change for major institutional investors …

Affiliated Managers earnings up next amid tax strategy scrutiny

Affiliated Managers Group Inc. is scheduled to report its second-quarter earnings, with investors keenly focused on how the company's management will address recent regulatory concerns regarding tax-aware investment strategies. Analysts predict earnings of $7.90 per share on revenue of $588.17 million. Despite a recent …

POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE

Amgen has announced that the CHMP of the European Medicines Agency has given a positive opinion for the expanded use of Repatha (evolocumab). This recommendation allows Repatha to be used for adults with established or high risk for atherosclerotic cardiovascular disease to reduce cardiovascular …

Amgen (AMGN) Stock Could Be A Bargain On Cash Flow But Fairly Priced On Earnings

Amgen stock has shown an 88.5% total return over the past five years. A Discounted Cash Flow (DCF) analysis suggests it is undervalued by 43.0% on cash flow, implying a potential bargain. However, its current P/E ratio of 27.2x, which is above the biotech …

Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients

Amgen is developing MariTide, a monthly injectable weight loss drug, aiming to compete with Eli Lilly's and Novo Nordisk's established treatments. While MariTide offers convenience with its once-a-month dosing, its phase 2 trial data showed less efficacy compared to rival drugs like Eli Lilly's …

Talon Private Wealth LLC Acquires Shares of 3,086 Amgen Inc. $AMGN

Talon Private Wealth LLC recently acquired 3,086 shares of Amgen Inc. (NASDAQ:AMGN) in the first quarter, valued at approximately $1,086,000. Other institutional investors have also adjusted their holdings, with Amgen's stock seeing a 4.5% increase and analysts providing mixed ratings, though the consensus remains …

Amgen Inc. $AMGN Stock Position Reduced by Amundi

Amundi decreased its ownership in Amgen Inc. (NASDAQ:AMGN) by 0.6% in the first quarter, selling 19,639 shares but still holding over 3.3 million shares worth $1.18 billion. While Amundi reduced its stake, other institutional investors like Parvin Asset Management and EverSource Wealth Advisors boosted …

Affiliated Managers Group (AMG) Q2 Earnings: What To Expect

Affiliated Managers Group (AMG) is set to report its Q2 earnings this Thursday, with analysts predicting a 19.2% year-on-year revenue growth. Last quarter, the company missed revenue expectations but beat EPS estimates. Peers BNY and State Street have already reported, showing revenue growth and …

Affiliated Managers (AMG) Is Up 8.7% After Raising Q2 2026 Adjusted EBITDA and Revenue Guidance

Affiliated Managers Group recently issued guidance indicating improved second-quarter 2026 adjusted EBITDA in the US$290 million to US$305 million range, alongside better revenues, ahead of its upcoming earnings release. This outlook, combined with a history of earnings surprises and supportive analyst indicators such as …

Iamgold Corp (IAG) Shares Fall 3.1% -- What GF Score of 71 Tells Investors

Shares of Iamgold Corp (IAG) recently fell 3.1%, continuing a downward trend. Despite a strong Financial Strength rating of 8/10, the stock is considered "Modestly Overvalued" by GuruFocus's GF Value™ at $14.26 against an estimated $12.54. The GF Score™ of 71/100 indicates above-average performance …

Amgen Inc Stock (AMGN) Moved Up by 4.02% on Jul 28: What Signal Does It Send?

Amgen Inc (AMGN) saw a 4.02% increase in its stock price, driven by strong second-quarter earnings that surpassed estimates and positive clinical data for its obesity drug MariTide. Technical indicators suggest a buy signal, though clinical safety concerns about MariTide and high pipeline dependency …

Amgen Q2 Results: Earnings call set for Aug 4 with CEO Bradway

Amgen Inc. is scheduled to release its second-quarter 2026 financial results on August 4, 2026, after the U.S. financial markets close. CEO Robert A. Bradway will lead a conference call at 4:30 p.m. ET to discuss financial performance, strategic initiatives, and pipeline developments. Live …

3 Asset Managers With Positive Earnings Surprise Potential in Q2

This article identifies three asset management firms—Affiliated Managers Group (AMG), Franklin Resources (BEN), and KKR & Co. (KKR)—that show strong potential for positive earnings surprises in Q2 2026. These companies are highlighted using Zacks' proprietary methodology, combining a positive Earnings ESP with a Zacks …

Avoiding Lag: Real-Time Signals in (AMG) Movement

This article provides a real-time analysis of Affiliated Managers Group Inc. (AMG) stock, highlighting a neutral near and mid-term outlook with a potentially positive long-term bias. It outlines distinct AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, emphasizing entry and …

Amgen stock hits all-time high at 391.3 USD

Amgen Inc. (NASDAQ: AMGN) stock has reached an all-time high of $391.42, trading close to its InvestingPro Fair Value of $392.58. This achievement is backed by a 28.64% total return over the past year and a PEG ratio of 0.83, indicating strong investor confidence …

Affiliated Managers Q2 Earnings on Deck: Here's What to Expect

Affiliated Managers Group Inc. (AMG) is set to release its second-quarter 2026 earnings, with expectations of improved year-over-year results stemming from strong AUM and higher revenues. The company has a notable earnings surprise history and is predicted to beat earnings again this quarter due …

Barclays Adjusts Amgen Price Target to $360 From $350, Maintains Equalweight Rating

Barclays has increased its price target for Amgen (NASDAQ: AMGN) to $360 from $350, while reiterating an "Equalweight" rating on the stock. This adjustment reflects the firm's updated valuation of the biotechnology company. Amgen remains a leading biotechnology group focused on drug sales for …

Empowered Funds LLC Sells 38,200 Shares of Amgen Inc. $AMGN

Empowered Funds LLC reduced its stake in Amgen Inc. by 32.0% in the first quarter, selling 38,200 shares and bringing its total holdings to $28.53 million. This comes amidst other institutional investors also adjusting their positions in the medical research company. Amgen's stock performance …

Earnings Preview: Amgen (AMGN) Q2 Earnings Expected to Decline

IAG|IAMGOLD Corp|Price:14.715|Chg%:+0.055

This article from TradingKey provides a comprehensive stock analysis of IAMGOLD Corp (IAG), highlighting its strong fundamentals, high growth potential, and relatively healthy financial state. Despite a recent weak stock market performance, the company shows steady revenue and profit growth. The analysis also covers …

AMG Critical Materials N.V. Successfully Closes the Acquisition of Zinnwald Lithium Plc.

AMG Critical Materials N.V. Amsterdam, 27 July 2026(Regulated Information) --- AMG Critical Materials N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") is pleased to confirm the transaction initially announced on May 14, 2026 to acquire the remaining c. 71% ownership interest in Zinnwald Lithium Plc. has been …

IAMGOLD Corp (IAG) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of IAMGOLD Corp (IAG), listing its major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding trends over recent quarters, and a list of related ETFs that include IAG. Key data points include the …

Affiliated Managers Group Inc (AMG) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical timeline of dividend payouts for Affiliated Managers Group Inc (AMG), indicating that a total of 6.20M USD has been distributed in dividends over the past five years. It lists upcoming interim and final cash dividends with their corresponding record, …

Amgen Stock Erased a 17% Drawdown. A MariTide Switch Study Explains Why.

Amgen (AMGN) has raised its 2026 revenue and non-GAAP EPS guidance, driven by strong growth in six key franchises. The company's stock has recovered significantly from a 17% drawdown, largely due to optimism surrounding its new Phase III MariTide SWITCH study, which tests converting …

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Amgen Inc. (AMGN) has attracted investor attention due to its recent stock performance and upcoming earnings report. While the company's shares have shown a 4.9% return in the last month, the Zacks Rank currently rates it as a #4 (Sell), suggesting potential underperformance in …

Orbimed Advisors LLC Purchases Shares of 39,900 Amgen Inc. $AMGN

Orbimed Advisors LLC has acquired 39,900 shares of Amgen Inc. (NASDAQ:AMGN) during the first quarter, totaling approximately $14,039,000. Several other institutional investors also increased their holdings in Amgen, which currently has 76.50% institutional ownership. Amgen recently reported strong quarterly earnings, beating analyst estimates, and …

Man Group PLC : Form 8.3 - AMG Critical Materials N.V

Man Group PLC FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Man Group PLC (b) Owner or …

Affiliated Managers Group Inc (AMG) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Affiliated Managers Group Inc (AMG), covering operating, investing, and financing activities. It presents financial data from FY2012Q1 through FY2026Q1, along with year-over-year percentage changes. The report also includes an FAQ section defining …

Amgen (AMGN) Beat Revenue Forecasts, Is The Stock Overvalued?

Amgen (AMGN) exceeded revenue forecasts with $8.62 billion, driven by double-digit growth across 16 brands, leading to positive investor response and significant share price returns. While a narrative suggests the stock is 4.5% overvalued at $376.04 compared to a fair value of $359.98, a …

ETFs Investing in IAMGOLD Corporation Stocks

This article lists various Exchange Traded Funds (ETFs) that hold shares of IAMGOLD Corporation. The ETFs are sorted by market value and include details such as their weight of IAMGOLD stock, issuer, management style, expense ratio, assets under management (AUM), price, and 3-year NAV …

Amgen Inc. $AMGN Shares Purchased by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp has increased its stake in Amgen Inc. by 23.1% in the first quarter, purchasing an additional 7,765 shares to bring its total holdings to 41,398 shares valued at approximately $14.6 million. This move is part of broader institutional ownership, with hedge …

Amgen Inc. $AMGN Shares Sold by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund reduced its stake in Amgen Inc. (NASDAQ:AMGN) by 53.4% in the first quarter, selling over 200,000 shares. Despite this, several other institutional investors increased their holdings, and institutions collectively own 76.50% of the company's stock. Amgen recently …

Entropy Technologies LP Buys Shares of 9,161 Amgen Inc. $AMGN

Entropy Technologies LP has acquired a new stake of 9,161 shares in Amgen Inc. (NASDAQ:AMGN), valued at approximately $3.223 million. Other institutional investors like Vanguard Group Inc. and State Street Corp have also increased their holdings in Amgen. Analyst ratings for Amgen are diversified, …